Zosano

IPO

Zosano Pharma | Migraine treatment | M207 | zolmitriptan

Public · Fremont, United States · $5.4M raised

Employees
11–50
Business Model
B2B
Total Funding
$5.4M
Last Round
$5.4M Series ADec 2019
Rounds
1
Type
Public

About

Painless, convenient transdermal patient administration of therapeutic proteins and vaccines

Summary

Zosano is a Biotech company based in Fremont, United States. It has raised $5.4M in total across 1 round, most recently a $5.4M Series A round in Dec 2019.

Tech & App Stack

3 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series ASeries ADec 2019
$5.4M

Similar Companies